www.fdanews.com/articles/63254-fda-approves-aurobindo-s-pediatric-powder-for-hiv-treatment
FDA APPROVES AUROBINDO'S PEDIATRIC POWDER FOR HIV TREATMENT
October 12, 2006
The US FDA has granted India-based Aurobindo a tentative approval for its Didanosine Oral Suspension (Pediatric Powder) 10 mg/ml. It is indicated for use in pediatric patients with HIV. BioSpectrum (http://www.biospectrumasia.com/content/111006IND1857.asp)